Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.
about
Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histologyUltra-High-Field MR Neuroimaging.Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Susceptibility-weighted imaging and quantitative susceptibility mapping in the brainCalcification in high grade gliomas treated with bevacizumab.Quantitative Susceptibility Mapping: Concepts and Applications.Advanced MR Imaging in Neuro-oncology.Overview of quantitative susceptibility mapping.The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping.Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mappingA method for estimating and removing streaking artifacts in quantitative susceptibility mapping.Bone quantitative susceptibility mapping using a chemical species-specific R2* signal model with ultrashort and conventional echo data.Diagnostic accuracy of susceptibility-weighted magnetic resonance imaging for the evaluation of pineal gland calcification.Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendorsCalcification in Globus Pallidus and Putamen of Multiple Sclerosis Patients Versus Healthy Subjects Using Quantitative Susceptibility Mapping.Radiological imaging features of glioblastoma with oligodendroglioma component: a comparison with conventional glioblastoma.Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis.Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational statusStability of R2* and quantitative susceptibility mapping of the brain tissue in a large scale multi-center study.Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages.Nuclei-specific deposits of iron and calcium in the rat thalamus after status epilepticus revealed with quantitative susceptibility mapping (QSM).Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.Susceptibility underestimation in a high-susceptibility phantom: Dependence on imaging resolution, magnitude contrast, and other parameters.Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.Potential of quantitative susceptibility mapping for detection of prostatic calcifications.An iterative spherical mean value method for background field removal in MRI.Effects of white matter microstructure on phase and susceptibility maps.Theoretical model of the single spin-echo relaxation time for spherical magnetic perturbers.Susceptibility-Based Differentiation of Intracranial Calcification and Hemorrhage in Pediatric Patients.Investigating magnetic susceptibility of human knee joint at 7 Tesla.Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy.Lesion magnetic susceptibility response to hyperoxic challenge: A biomarker for malignant brain tumor microenvironment?The impact of white matter fiber orientation in single-acquisition quantitative susceptibility mapping.Infiltrative patterns of glioblastoma: Identification of tumor progress using apparent diffusion coefficient histograms.Susceptibility Weighted MRI in Rodents at 9.4 T.[Computational neuroanatomy and microstructure imaging using magnetic resonance imaging].
P2860
Q28544667-E8D4A7F9-B62B-441F-880B-70652FB807C2Q30401687-2BF1E91A-BEEB-4790-A431-52350E3DA8C0Q30837513-470EE28E-0BBF-4B6A-A534-217677E4E862Q30856540-A0FADEF9-7B8C-4ED6-AE73-2790097202FCQ30943748-3A7A8259-0F1A-49CE-991D-80EA1E32F0B6Q30982002-5EC627DC-3275-4F8F-9775-6E85F9C88ABFQ30983681-6C14D279-8BB0-4E6F-9B6B-45CDEB4BC378Q31115799-0C370E2D-8B12-4DDA-9172-8B02AA2BD6D7Q31146333-30C39316-088C-4E3D-AEC3-B710757E9E42Q33698886-E73FF5EC-A3FF-45CA-BC25-60EC375AB599Q34495438-0580B14E-AF0A-4944-9CC9-055DC4932F4DQ34626246-A9B0D823-7A6C-4D0E-8F85-03B61B881C5CQ35521721-B2FDF728-5242-4F25-A701-119A895F91C7Q36297808-DBF33F1C-21B3-48A7-8BEB-8119C1F31603Q36302815-99EE90D9-EA38-4C2C-B9BD-55D6CA297501Q36322681-6395ED99-45C0-4C6C-B4BD-1F73D79D9B72Q37424059-5302571A-2976-4A25-AAB8-FBA251E3E04EQ37436717-8583306F-F061-41D2-A425-526E007553D1Q37497458-02C7DF03-9FC7-428B-9676-777164FA3DDEQ37677994-0C2EC4D8-D13F-4FE3-84A3-614F8FA9C628Q37724037-F5E6536F-3555-4C9C-97B7-232E495EE358Q38632703-F589E712-E616-4FCD-AD96-12F788331309Q38683194-46E9536A-8E75-4A02-B3D6-9224F2109AFFQ38744249-B1D8F389-A56F-43E4-BBA4-E294D53DB329Q38844807-E7253AE5-B16F-4B3E-8D92-1461F5BFD95BQ39179797-92E06DD5-5D40-4B45-AB85-CF2D6447491AQ39325304-E0D2B634-E2E3-4475-A61D-61F5486858C8Q39382061-35DDF460-3C82-4ADB-BCB1-6A6B5B3DA68AQ39600655-06441667-157D-4405-AEB6-C446EEA9A1BAQ39749251-374E995D-D1FD-4A79-A661-9B0ADB6EA3DFQ41858949-83BFEA69-56AE-47F8-B562-5D778816FB75Q43426820-17CF11D2-8918-4B81-9859-07B9DA9DB1A1Q44673304-12D2CF3F-637F-457A-8E78-B0F4CF0ECBEAQ45969253-786B850A-8D0F-4FA6-A7DE-0E36B932C1D1Q47162047-A491421E-C1F0-4410-924E-FC536337A7D0Q47267468-FE0C6F7C-BA4C-4D3B-85E1-0F2FBC364A62Q47688746-3FDF9940-2A8B-4610-8841-7C824F9B3B16Q48941681-49FBC0AD-E882-48D8-A2CC-C3385F7747EDQ50012218-82A33FBE-1429-4C9A-A20E-8BD83FF96C1BQ50526101-4D4CA755-93C8-473C-B8D2-FBBA8A27DC20
P2860
Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Quantitative susceptibility ma ...... in patients with glioblastoma.
@ast
Quantitative susceptibility ma ...... in patients with glioblastoma.
@en
Quantitative susceptibility ma ...... in patients with glioblastoma.
@nl
type
label
Quantitative susceptibility ma ...... in patients with glioblastoma.
@ast
Quantitative susceptibility ma ...... in patients with glioblastoma.
@en
Quantitative susceptibility ma ...... in patients with glioblastoma.
@nl
prefLabel
Quantitative susceptibility ma ...... in patients with glioblastoma.
@ast
Quantitative susceptibility ma ...... in patients with glioblastoma.
@en
Quantitative susceptibility ma ...... in patients with glioblastoma.
@nl
P2093
P2860
P50
P1433
P1476
Quantitative susceptibility ma ...... in patients with glioblastoma.
@en
P2093
Ferdinand Schweser
Heinz-Peter Schlemmer
Mario Abello
Matthias Roethke
Sabine Heiland
P2860
P304
P356
10.1371/JOURNAL.PONE.0057924
P407
P50
P577
2013-03-21T00:00:00Z